UPDATE: Video with more info, medication protocol, source info and contact here.
Stumping for my friend here, who's on to something in a big way, but who is meeting resistance from other medical entities who wish to claim the discovery for themselves. Press: Contact Dr. Bowers or myself for more.
While the world scrambles to find a cure, a Seattle internist working for Dr. James Bowers, MD, has discovered a 3-drug combination which successfully keeps COVID-19-positive patients alive. Working with a group of twenty-plus infected elderly residents at a North Seattle nursing home, Bowers and crew were shocked and delighted to find that in every case, administration of this cocktail prevents patients from dying or advancing to severe illness.
The cocktail, based on studies previously conducted during the SARS and MERS epidemics, works by preventing the coronavirus’ fatal ability to damage the lungs by stopping the onset of Acute Respiratory Distress Syndrome (ARDS). While not a cure for the virus in strict terms, Bowers’ cocktail effectively and conclusively prevents COVID-19 from being lethal. As he explains, “This combination represents a different way of treating COVID-19 by changing the way our body reacts to the virus by preventing it from OVER-reacting to it.” The repercussions of transforming the coronavirus into a non-fatal health issue are, of course, seismic.
Particularly noteworthy is that all of Bowers’ patients are among COVID-19’s most vulnerable targets– weak and elderly individuals, many of whom already have preexisting illnesses and compromised immune systems. In addition to a 100% success rate of suppressing ARDS with these patients, the medication has also shown no severe side effects. Bowers and co. were thrilled to see the drug combination even work with an infected patient in her early nineties, no doubt saving her life. Indeed, the only patient in the group exhibiting failing health is also the only one to refuse Bowers’ treatment, tragically– if inadvertently– further confirming the cocktail’s efficacy.
“Viruses have been around longer than humans and have learned to adapt,” says Dr. Bowers, a former chief of staff at Northwest Hospital. “We are dealing with an especially efficient virus in COVID-19. This drug combination is just a start into coming up with more effective therapies, but right now it is the only thing we have to fight COVID-19.”
Dr. Bowers is calling on pharmaceutical companies to work quickly with medical providers to address the crisis. “The goal is to get hospitals in the Seattle area to use this protocol in the hope that local foundations such as the Gates Foundation will help spread the word and support this effort.”
The shortest, fastest time a vaccine has taken to get from testing to public access was for the Ebola virus, and that took six years. The discoveries and proven success of Dr. Bowers and his team represent the first major breakthrough in the fight to stop COVID-19.
Stumping for my friend here, who's on to something in a big way, but who is meeting resistance from other medical entities who wish to claim the discovery for themselves. Press: Contact Dr. Bowers or myself for more.
While the world scrambles to find a cure, a Seattle internist working for Dr. James Bowers, MD, has discovered a 3-drug combination which successfully keeps COVID-19-positive patients alive. Working with a group of twenty-plus infected elderly residents at a North Seattle nursing home, Bowers and crew were shocked and delighted to find that in every case, administration of this cocktail prevents patients from dying or advancing to severe illness.
The cocktail, based on studies previously conducted during the SARS and MERS epidemics, works by preventing the coronavirus’ fatal ability to damage the lungs by stopping the onset of Acute Respiratory Distress Syndrome (ARDS). While not a cure for the virus in strict terms, Bowers’ cocktail effectively and conclusively prevents COVID-19 from being lethal. As he explains, “This combination represents a different way of treating COVID-19 by changing the way our body reacts to the virus by preventing it from OVER-reacting to it.” The repercussions of transforming the coronavirus into a non-fatal health issue are, of course, seismic.
Particularly noteworthy is that all of Bowers’ patients are among COVID-19’s most vulnerable targets– weak and elderly individuals, many of whom already have preexisting illnesses and compromised immune systems. In addition to a 100% success rate of suppressing ARDS with these patients, the medication has also shown no severe side effects. Bowers and co. were thrilled to see the drug combination even work with an infected patient in her early nineties, no doubt saving her life. Indeed, the only patient in the group exhibiting failing health is also the only one to refuse Bowers’ treatment, tragically– if inadvertently– further confirming the cocktail’s efficacy.
“Viruses have been around longer than humans and have learned to adapt,” says Dr. Bowers, a former chief of staff at Northwest Hospital. “We are dealing with an especially efficient virus in COVID-19. This drug combination is just a start into coming up with more effective therapies, but right now it is the only thing we have to fight COVID-19.”
Dr. Bowers is calling on pharmaceutical companies to work quickly with medical providers to address the crisis. “The goal is to get hospitals in the Seattle area to use this protocol in the hope that local foundations such as the Gates Foundation will help spread the word and support this effort.”
The shortest, fastest time a vaccine has taken to get from testing to public access was for the Ebola virus, and that took six years. The discoveries and proven success of Dr. Bowers and his team represent the first major breakthrough in the fight to stop COVID-19.
RSS Feed
